Skip to main content

OptiNose, Inc.

OPTNDelisted May 21, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001494650

OptiNose, Inc. was delisted on May 21, 2025; its insiders filed their last Form 4 on May 21, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $65.6M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding OptiNose, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of OPTN: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders84165−18
Shares109.6M5.27M108.8M+4.49M (+4.3%)
Value$114.3M$5.49M$72.7M−$36.2M (−33.2%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held OptiNose, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to OPTN in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.778,380$521.5K0.00%
J. Goldman & Co LP675,000$452.3K0.02%
Gsa Capital Partners LLP91,084$61.0K0.00%
Aster Capital Management (DIFC) Ltd58,480$39.2K0.01%
AJOVista, LLC11,307$7.58K0.03%

Sold out (23)

Institutions that held OptiNose, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (1)

Institutions that held OptiNose, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OPTN in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.5,274,114$5.49M